| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030820 |
| Receipt No. | R000035117 |
| Official scientific title of the study | Study on effects of long-term ingestion of beta-cryptoxanthin-rich mandarin orange juice on body fat. |
| Date of disclosure of the study information | 2018/01/25 |
| Last modified on | 2018/07/02 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study on effects of long-term ingestion of beta-cryptoxanthin-rich mandarin orange juice on body fat. | |
| Title of the study (Brief title) | Effects of mandarin orange juice on body fat. | |
| Region |
|
|
| Condition | ||
| Condition | obesity | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effects of long-tern ingestion of beta-cryptoxanthin-rich mandarin orange juice on suppression of body fat. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Visceral fat area |
| Key secondary outcomes | Body weight,BMI,Waist length,Body fat percentage |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The subjects ingested the active meal for eight weeks. | |
| Interventions/Control_2 | The subjects ingested the placebo meal for eight weeks. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Healthy male and female between 20 and 70 years old 2) Individuals who can refrain from drinking and eating during the test period 3) Individuals who understand the purpose and contents of the experiment |
|||
| Key exclusion criteria | 1)Individuals taking drugs, supplements and healthy foods which affect the blood lipid metabolism 2)Those who can not stop taking supplements or health foods that may affect lipid metabolism during the test period 3)Subjects who are contracting or treating severe diabetes mellitus,kidney and/or liver diseases 4)Those who have been diagnosed with diabetes 5)Individuals with a chronic diseases 6)Those who can not stop taking a large amount of juice during the test period 7)Pregnant women, or women with intending to become pregnant, and lactating woman 8)Individuals participating or intending to participate in a drug administration test 9)Individuals judged by the doctor to be unsuitable |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kazunari Tanaka |
| Organization | Univercity of Nagasaki |
| Division name | Faculty of Nursing and Nutrition |
| Address | 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195 |
| TEL | 095-813-5216 |
| katanaka@sun.ac.jp | |
| Public contact | |
| Name of contact person | Hideki Ito |
| Organization | Univercity of Nagasaki |
| Division name | Regional Collaboration Center |
| Address | 1-1-1 Manabino, Nagayo-cho, Nishisonogi-gun, Nagasaki, Japan, 851-2195 |
| TEL | 095-813-5500 |
| Homepage URL | |
| katanaka@sun.ac.jp | |
| Sponsor | |
| Institute | University of Nagasaki |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nagasak prefecture |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035117 |